55 related articles for article (PubMed ID: 35616231)
21. Does it actually feel right? A replication attempt of the rounded price effect.
Harms C; Genau HA; Meschede C; Beauducel A
R Soc Open Sci; 2018 Apr; 5(4):171127. PubMed ID: 29765625
[TBL] [Abstract][Full Text] [Related]
22. Relationship between Investor Sentiment and Price Fluctuation of SSE 50ETF Options.
Wang Y; Zhang Y; Fu Y
Comput Intell Neurosci; 2022; 2022():8992779. PubMed ID: 35814599
[TBL] [Abstract][Full Text] [Related]
23. Transparency in Coverage Data and Variation in Prices for Common Health Care Services.
Chartock BL; Simon K; Whaley CM
JAMA Health Forum; 2023 Oct; 4(10):e233663. PubMed ID: 37889484
[TBL] [Abstract][Full Text] [Related]
24. The time cost of saving money: detouring and connecting time losses in the virtually interlined European airport network.
Meire S; Derudder B
Eur Transp Res Rev; 2022; 14(1):26. PubMed ID: 38625251
[TBL] [Abstract][Full Text] [Related]
25. Pricing of HPV vaccines in European tender-based settings.
Qendri V; Bogaards JA; Berkhof J
Eur J Health Econ; 2019 Mar; 20(2):271-280. PubMed ID: 30051152
[TBL] [Abstract][Full Text] [Related]
26. [Health technology assessment report: Computer-assisted Pap test for cervical cancer screening].
Della Palma P; Moresco L; Giorgi Rossi P
Epidemiol Prev; 2012; 36(5 Suppl 3):e1-43. PubMed ID: 23139174
[TBL] [Abstract][Full Text] [Related]
27. Effects of Volume-Price Contracts on Pharmaceutical Prices: A Retrospective Comparative Study of Public Hospitals in Hubei of China.
Li Z; Liu C; Zuo K; Liu J; Tang Y
Front Pharmacol; 2021; 12():741671. PubMed ID: 34721029
[No Abstract] [Full Text] [Related]
28. Cost-effectiveness of cervical cancer prevention in Central and Eastern Europe and Central Asia.
Berkhof J; Bogaards JA; Demirel E; Diaz M; Sharma M; Kim JJ
Vaccine; 2013 Dec; 31 Suppl 7():H71-9. PubMed ID: 24332299
[TBL] [Abstract][Full Text] [Related]
29. Epidemiology and cost of cervical cancer care and prevention in Apulia (Italy), 2007/2016.
Bianchi FP; Gallone MS; Fortunato F; Boccalini S; Martinelli D; Prato R; Tafuri S
Ann Ig; 2018; 30(6):490-501. PubMed ID: 30614498
[TBL] [Abstract][Full Text] [Related]
30. Pricing of HPV tests in Italian tender-based settings.
Inturrisi F; Berkhof J
J Med Econ; 2022; 25(1):762-768. PubMed ID: 35616231
[TBL] [Abstract][Full Text] [Related]
31. Primary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plans.
Maver PJ; Poljak M
Clin Microbiol Infect; 2020 May; 26(5):579-583. PubMed ID: 31539637
[TBL] [Abstract][Full Text] [Related]
32. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
[TBL] [Abstract][Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
